Nodict 50 is a generic oral tablet containing naltrexone 50mg, a non-addictive opioid receptor antagonist widely used in the treatment of alcohol and opioid dependence. By binding strongly to mu-opioid receptors without activating them, it prevents the reinforcing and euphoric effects of alcohol and narcotics. This mechanism makes it a valuable tool for relapse prevention in patients who have completed detoxification and are ready to commit to long-term recovery. Nodict 50 is most effective when combined with psychological counseling and social support. It breaks the cycle of reward and craving, helping individuals regain control over their behavior. In addition to its use in substance abuse treatment, emerging research supports its application at lower doses (Low-Dose Naltrexone, LDN) for managing conditions like chronic depression, inflammation, and autoimmune disorders. Its ability to modulate reward pathways, reduce cravings, and influence neuroinflammation makes Nodict 50 a multipurpose therapy that aligns well with comprehensive mental health strategies.

- Sleep & Mental Health > Alcoholism Used to reduce cravings and alcohol intake by blocking the reward response triggered by alcohol consumption. A key component in maintaining long-term sobriety in individuals with alcohol use disorder. - Sleep & Mental Health > Depression (Low-Dose Naltrexone) Investigational use of low-dose naltrexone (typically 1–5 mg) has shown promise in modulating mood by reducing neuroinflammation, aiding patients with treatment-resistant depression. - Sleep & Mental Health > Obsessive-Compulsive Disorder (OCD) May help regulate compulsive urges and behavioral dysregulation when used alongside standard treatments in select refractory OCD cases.

Naltrexone acts by selectively and competitively inhibiting opioid receptors in the central nervous system, especially the mu-opioid receptor. This antagonism prevents opioids and alcohol from producing their usual reinforcing effects, thereby lowering the likelihood of continued use or relapse. In alcohol addiction, the reduction in dopamine release in the nucleus accumbens reduces the psychological “high” associated with drinking. In opioid dependence, it renders any attempted use ineffective. At lower doses, naltrexone may also reduce glial cell activity and support endorphin regulation, enhancing emotional balance and potentially benefiting patients with chronic pain, inflammation, or mood disorders. Nodict 50 provides a stable, once-daily oral solution with no abuse potential and good tolerability when monitored correctly.

Usual Adult Dose for Alcohol Dependence (Oral): → 50 mg orally once daily Duration: Typically 12 weeks, but can be extended based on individual treatment needs. Usual Adult Dose for Alcohol Dependence (Intramuscular): → 380 mg intramuscularly once every 4 weeks Usual Adult Dose for Opiate Dependence (Oral): → Initial dose: 25 mg orally once daily → Maintenance dose: 50 mg orally once daily (if tolerated without withdrawal symptoms) Usual Adult Dose for Opiate Dependence (Intramuscular): → 380 mg intramuscularly once every 4 weeks Comments: - Initiation requires the patient to be opioid-free for 7 to 14 days to avoid severe withdrawal. - Patients switching from methadone or buprenorphine may be especially vulnerable to precipitated withdrawal. - Use symptom management with non-opioid agents if necessary. - Best outcomes are achieved when therapy is part of a comprehensive relapse prevention program that includes behavioral therapy, family support, and consistent monitoring.

Store in a cool, dry place below 25°C. Keep away from light, humidity, and heat sources. Ensure the container remains tightly sealed and stored securely out of children’s reach.

Common side effects: nausea, fatigue, dizziness, headache, insomnia Occasional: decreased libido, anxiety, joint pain, abdominal discomfort Rare but serious: liver toxicity, depression, allergic skin reactions, suicidal ideation Regular liver function tests and psychological assessments are advised during prolonged treatment.